STOCK TITAN

Alimera Sciences to Present at the Q1 Investor Summit Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Alimera Sciences (Nasdaq: ALIM) will present a corporate overview at the virtual Q1 Investor Summit Conference on March 9, 2022, at 8:45 AM ET. Rick Eiswirth, President and CEO, along with CFO Phil Jones, will be available for one-on-one investor meetings on the same day. This event highlights Alimera's commitment to partnering with patients and physicians to enhance retinal health and vision longevity. For more information and registration details, visit Alimera's official site.

Positive
  • None.
Negative
  • None.

ATLANTA, March 02, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will present a corporate overview at the Q1 Investor Summit Conference, which is being held virtually on March 8 – 9, 2022.

Mr. Eiswirth will deliver his corporate presentation on Wednesday, March 9, 2022 at 8:45 AM ET.

Additionally, Mr. Eiswirth and Phil Jones, Alimera’s Chief Financial Officer, will be available for one-on-one investor meetings on Wednesday, March 9, 2022.

Click here to register: Q1 Investor Summit - INVESTOR REGISTRATION

About Alimera Sciences, Inc.

Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.

For press inquiries:
Jules Abraham
for Alimera Sciences
917-885-7378
julesa@coreir.com

For investor inquiries:
Scott Gordon
for Alimera Sciences
scottg@coreir.com


FAQ

What is Alimera Sciences presenting at the Q1 Investor Summit Conference?

Alimera Sciences will present a corporate overview on March 9, 2022, at 8:45 AM ET.

Who will be presenting at the Q1 Investor Summit for Alimera?

Rick Eiswirth, President and CEO, will present, with CFO Phil Jones available for investor meetings.

When is the Q1 Investor Summit Conference for Alimera Sciences?

The Q1 Investor Summit Conference is on March 8-9, 2022.

How can I register for Alimera Sciences' Q1 Investor Summit presentation?

You can register for the Q1 Investor Summit through Alimera's official site.

Is Alimera Sciences focused on retinal health?

Yes, Alimera Sciences focuses on retinal health and maintaining better vision longer.

Alimera Sciences, Inc.

NASDAQ:ALIM

ALIM Rankings

ALIM Latest News

ALIM Stock Data

301.29M
51.48M
5.35%
86.54%
1.06%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
ALPHARETTA